✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

Of the nootropic peptides developed in Russia and subsequently studied elsewhere, Adamax is arguably the most refined. It takes the backbone of Semax — the ACTH(4-10)-derived heptapeptide that has been used pharmaceutically in Russia for decades — and modifies it in two specific ways: an N-terminal acetyl group to slow enzymatic degradation, and a C-terminal adamantane moiety to improve bioavailability and extend half-life. The result is a nine-amino-acid research peptide engineered specifically to address Semax’s main pharmacokinetic limitations.

Adamax is not a mainstream nootropic. It is a research compound used in Russian cognitive-peptide studies and by advanced biohackers exploring ACTH-derived peptides for cognition and neuroprotection. Its user base is smaller than Semax’s, its research base is narrower, but its mechanism — modulation of BDNF through MC4R and TrkB receptor sensitisation — is a logical extension of its parent peptide’s pharmacology.

This guide covers what Adamax actually is, how it differs from Semax, what the published research shows, how dosing protocols are structured, the safety picture, and where Adamax fits alongside its Semax parent and other cognitive peptides.

Adamax Peptide: Nootropic, Dosage & The Honest Science (2026)

Last updated: April 17, 2026 · Reviewed by a licensed pharmacist (MedsBase Medical Team)

What Is Adamax? (Definition & Background)

Adamax is formally designated N-Acetyl Semax-Adamantane. It is a nine-amino-acid research peptide built on the Semax backbone (Met-Glu-His-Phe-Pro-Gly-Pro — itself derived from ACTH(4-10)) with two key pharmacokinetic modifications: an N-terminal acetyl group to reduce proteolytic degradation at the amino terminus, and a C-terminal adamantane (a rigid hydrophobic carbon cage) to further stabilise the molecule and improve cellular uptake.

The molecule was developed in Russian research laboratories — particularly the Institute of Molecular Genetics at the Russian Academy of Sciences — as an attempt to overcome the main clinical limitation of Semax: its relatively short duration of action per intranasal dose. By both blocking proteolytic breakdown and improving bioavailability, Adamax extends the window of BDNF-modulating activity from hours (Semax) to an entire day per dose.

Adamax is a research peptide, not an approved pharmaceutical anywhere. Its primary use is in academic and research settings for cognitive-peptide studies and, in the consumer space, by advanced users already familiar with Semax who want a longer-duration analog. The user base is much smaller than Semax’s, which means experiential data (what dose works for what use case) is less well-established.

That said, the preclinical research base — almost entirely Russian — is reasonable by peptide-field standards, with preclinical animal studies confirming cognitive enhancement, BDNF modulation, and post-stroke recovery benefits at doses in the 5–15 mg/day range.

How Does Adamax Work? (Mechanism & Science)

Adamax’s mechanism overlaps heavily with Semax’s but is extended by the longer half-life and improved bioavailability.

1. MC4 Receptor Activation

Like Semax, Adamax activates melanocortin-4 receptors (MC4R) in brain regions governing attention, motivation, and sexual arousal. The MC4R activation is thought to be the primary behavioural-activation component of the peptide’s effect.

2. BDNF Upregulation

Following MC4R activation, Adamax triggers a cascade that upregulates BDNF expression in the hippocampus. BDNF is the signal that supports synaptic plasticity, neuronal survival, and long-term potentiation — the cellular basis of learning. This is the shared mechanism with Semax.

3. TrkB Receptor Sensitisation

Adamax additionally increases the sensitivity of the TrkB receptor (BDNF’s receptor) in the hippocampus. Higher receptor sensitivity means a given amount of BDNF produces a larger cellular response — compounding the effect of BDNF upregulation.

4. Extended Half-Life (vs Semax)

The adamantane modification and N-acetylation collectively extend Adamax’s plasma half-life from roughly 30–60 minutes (Semax) to several hours. For users, this translates to fewer doses per day and more consistent BDNF-modulating activity across a work or study session.

Key Uses & Applications

Cognitive Enhancement (Most Common Research Use)

Adamax is used primarily for focus, memory, and learning support — similar indications to Semax, with the added advantage of longer per-dose duration. Subjective reports describe clearer focus on demanding cognitive tasks and improved learning on novel material.

Post-Stroke Recovery (Preclinical + Small Clinical)

Russian preclinical studies and small human studies have explored Adamax in stroke-recovery protocols. The mechanism — MC4R/BDNF/TrkB activation — fits well with neurorehabilitation pharmacology.

Neuroprotection

Preclinical models show Adamax has neuroprotective effects in ischemic and excitotoxicity models. Clinical human data in specific neurodegenerative conditions is limited.

Advanced Biohacking / Research Stacks

Among advanced users familiar with Semax, Adamax is used as a longer-duration substitute or as a rotation partner (Semax during work blocks, Adamax during extended cognitive work). Stacking with other nootropics is common.

Safety Profile, Side Effects & Dosage

Reported Side Effects

• Mild nasal irritation — common with intranasal dosing; transient.
• Mild headache — occasional, typically during first several doses.
• Mild insomnia — if dosed late in the day; the extended half-life makes evening dosing more problematic than with Semax.
• Rare allergic reactions — typical for any peptide.

No major adverse effects have been reliably reported in the available preclinical or small-scale clinical literature.

Dosage Reference Ranges

• Standard research dose: 5–15 mg/day intranasally, typically as a single morning dose.
• Starter dose: 2–5 mg/day for first week to assess tolerance.
• Upper ceiling: 15 mg/day (above this, Russian data suggests no additional benefit).
• Cycle length: 4–8 weeks on, 2–4 weeks off is a reasonable cycling pattern.

Contraindications

Pregnancy, breastfeeding, seizure disorder (caution), severe hypertension, and severe hepatic or renal impairment. Avoid late-day dosing to prevent sleep disruption.

What Does the Research Say?

Preclinical Animal Studies

Russian preclinical studies show Adamax produces cognitive enhancement, improved learning, and neuroprotection in rodent models at doses of 5–15 mg/kg. The 2023 Institute of Molecular Genetics study confirmed a 10–15 mg/injection dose-response plateau in rats.

Post-Stroke Recovery

Small Russian human studies have reported improved post-stroke recovery with Adamax compared to placebo. Effect sizes are modest but directionally positive.

BDNF / TrkB Pharmacology

The BDNF/TrkB modulation mechanism is a logical extension of Semax’s well-characterised pharmacology. Adamax’s specific pharmacology of TrkB sensitisation appears slightly more potent than Semax’s at the receptor level.

Long-Term Safety Data

Limited. The user base is smaller than Semax’s, and formal long-term safety studies have not been published. Available short-term data is favourable.

Adamax vs Semax vs Other Nootropics

Practical takeaway. Adamax is Semax’s bigger, longer-lasting sibling. For users who already know how Semax feels and want a longer window per dose, Adamax is the logical upgrade. For beginners to this peptide family, Semax remains the recommended starting point.

How to Use Adamax (Reconstitution, Storage, Administration)

Reconstitution

Adamax ships as lyophilised powder in 5 mg or 10 mg vials. For a 5 mg vial with 1 mL bacteriostatic water: 5 mg/mL, each drop (~0.05 mL) delivers ~250 mcg, so 2 mg requires ~8 drops or 0.4 mL.

Storage

Reconstituted Adamax is stable refrigerated (2–8 °C) for 2–4 weeks. Unreconstituted vials keep indefinitely frozen.

Intranasal Administration

Administer via dropper or intranasal spray. Tilt head back slightly; administer 1–2 drops per nostril; avoid blowing nose for 15+ minutes. Morning dosing is preferred — the extended half-life can disrupt evening sleep.

Cycle Structure

Typical cycling pattern is 4–8 weeks on, 2–4 weeks off. Continuous daily dosing is possible but less well-studied.

Frequently Asked Questions

What is Adamax used for?

Adamax is used primarily for cognitive enhancement — focus, memory, learning — and in preclinical research for post-stroke recovery and neuroprotection. Outside Russia, it is used off-label or as a research compound in advanced biohacking protocols.

Is Adamax a peptide?

Yes. Adamax is a nine-amino-acid synthetic peptide derived from Semax (itself an ACTH(4-10) analog), with an N-acetyl group and a C-terminal adamantane modification for pharmacokinetic stability.

Is Adamax stronger than Semax?

Not stronger per molecule, but longer-lasting. Adamax’s half-life is several hours vs Semax’s roughly 30–60 minutes, and its TrkB receptor sensitisation may be modestly stronger. For a similar behavioural effect, users need fewer doses of Adamax per day.

How quickly does Adamax work?

Onset 20–40 minutes after intranasal dosing; peak effect around 1–2 hours; duration 6–8 hours per dose. This is longer than Semax, making single-dose daily protocols more practical.

How much Adamax should I use?

Research dose is 5–15 mg/day, typically as a single morning intranasal dose. Starter doses of 2–5 mg/day can be used for the first week to assess tolerance. Above 15 mg/day, additional cognitive benefit is unlikely per the available Russian preclinical data.

Can Adamax replace Semax?

For users who want longer per-dose duration, yes. Beginners to this peptide class should still start with Semax because of its shorter half-life and smaller per-dose risk. Some users rotate between them rather than replacing.

Can I stack Adamax with other peptides?

Yes. Common pairings include Adamax + Selank (cognition + anxiolytic coverage), Adamax + NAD⁺ (neuroplasticity + mitochondrial support), and Adamax + recovery peptides like BPC-157 during high-cognitive-load training blocks.

Is Adamax legal?

Adamax is sold as a research compound in the US, EU, UK, and most jurisdictions and is not approved for human therapeutic use by any major regulator. Check local laws before purchase.

Is Adamax addictive?

No. No withdrawal syndrome or dependence potential has been reported in the available literature. Cycling is still recommended to preserve receptor sensitivity.

The Bottom Line — Is Adamax Worth It?

Adamax is Semax reengineered for extended duration. For users who have already experienced Semax and want fewer-doses-per-day coverage of BDNF-modulating activity, Adamax is the logical upgrade. For beginners to the ACTH-derived nootropic family, Semax remains the recommended entry point.

The honest limitations: the user base is smaller, the research base is narrower, and long-term safety data is less developed than Semax’s. Anyone using Adamax is operating in a more experimental space than with its parent peptide.

For researchers, advanced biohackers, and clinicians exploring neuropeptide-based cognitive enhancement, Adamax earns a place in the toolkit — particularly for use cases where the extended half-life matters (long work sessions, sustained research tasks). When sourcing, verified Adamax at MedsBase ships with full documentation and pharmaceutical-grade purity in 5 mg and 10 mg vials. For the foundational nootropic peptide, read our Semax guide; for mitochondrial cognitive support, see our NAD⁺ guide.

Related Guides

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.